Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693700013 | Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693701012 | Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing neomycin in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Hydrocortisone and neomycin only product | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Hydrocortisone and neomycin only product in otic dose form | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Compound neomycin preparations (product) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing neomycin in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Topical neomycin (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Skin anti-infective (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Neomycin (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Hydrocortisone (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing hydrocortisone and neomycin (medicinal product) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Corticosterone | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Adrenal hormone agent (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Local anti-infective (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a une forme pharmaceutique (attribut) | Conventional release ear or eye drops (dose form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength denominator unit | Milliliter (qualifier value) | false | Inferred relationship | Some | 2 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength denominator unit | Milliliter (qualifier value) | false | Inferred relationship | Some | 1 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | a une forme pharmaceutique (attribut) | Conventional release solution for ear or eye drops (dose form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing neomycin in ophthalmic dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Hydrocortisone-containing product in otic dose form | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing neomycin in otic dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | est un(e) (attribut) | Product containing hydrocortisone in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength numerator value (attribute) | cinq | false | Inferred relationship | Some | 1 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has concentration strength numerator value (attribute) | 15 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has precise active ingredient | Hydrocortisone acetate | false | Inferred relationship | Some | 2 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has basis of strength substance (attribute) | Hydrocortisone acetate | false | Inferred relationship | Some | 2 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has precise active ingredient | Neomycin sulfate | false | Inferred relationship | Some | 1 | |
| Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution | Has basis of strength substance (attribute) | Neomycin sulfate | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR